产品: 磷酸化 CENPA (Ser7) 抗体
货号: AF2330
描述: Rabbit polyclonal antibody to Phospho-CENPA (Ser7)
应用: WB IHC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Horse, Rabbit
蛋白号: P49450
RRID: AB_2845344

浏览相似产品>>

   规格 价格 库存
 100ul RMB¥ 2800 现货
 200ul RMB¥ 3800 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Phospho-CENPA (Ser7) Antibody detects endogenous levels of CENPA only when phosphorylated at Ser7.
RRID:
AB_2845344
引用格式: Affinity Biosciences Cat# AF2330, RRID:AB_2845344.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

CENP A; CENP-A; cenpa; CENPA_HUMAN; Centromere autoantigen A; Centromere protein A 17kDa; Centromere protein A; Histone H3 like centromeric protein A; Histone H3-like centromeric protein A;

抗原和靶标

免疫原:

A synthesized peptide derived from human CENPA around the phosphorylation site of Ser7.

基因/基因ID:

文献引用

1). A Tumor Suppressive Role of CYLD as a Novel Potential DUB of Aurora B in Cervical Cancer. Clinical Medicine Insights. Oncology, 2023 (PubMed: 37359274) [IF=2.2]

Application: WB    Species: human    Sample:

Figure 3. CYLD regulates Aurora B activity and function. (A) HeLa cells transfected with CYLD or control plasmid were synchronized by nocodazole for 18 h before harvested. Mitotic HeLa cells were collected by mitotic shake-off. The collected cells were then continued to incubate for the indicated time points (0, 1, 3 h) and following immunoblotted with indicated antibodies. (B) HeLa cells transfected with control or Flag-CYLD plasmid were synchronized by nocodazole for 18 h and then were fixed for IF analysis with indicated antibodies. Scale bar represents 2 μm. (C) Luciferase control and 2 clones of CYLD knock-down stable HeLa cells were generated and harvested for WB assay with indicated antibodies. (D) Luciferase control or CYLD knock-down stable HeLa cells generated above were synchronized by nocodazole for 18 h and then fixed for IF analysis with indicated antibodies. Scale bar represents 2 μm. (E) HeLa cells expressing H2B-GFP were transfected with control or CYLD plasmid; 36 h later, cells were imaged at every 5 min. Around 100 cells in each group were randomly chosen for statistics. The upper panel showed the representative fluorescence video microscopy series from the onset of mitosis to monitor chromosome dynamics and the lower panel displayed the statistical results. Cell numbers were 123 (Control) and 123 (CYLD). P value was calculated using unpaired T-test. Error bars represent the standard deviation. Scale bar represents 5 μm. (F) Control and CYLD stable knock-down SiHa cervical cancer cells were plated and cultured for 24 h; cells were then stained with Hoechst. Later, more than 30 random pictures of every group were captured under a confocal microscope. Finally, we counted and summed up the proportion of cells with micronuclei. The left panel showed a representative micronuclei microscopy of the cells and the right panel displayed the statistical results. For each group, the cell number is more than 1000. P value was calculated using unpaired T-test. Scale bar represents 2 μm.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.